Gene Symbol | Gene ID | Gene Info |
---|---|---|
ELK4
|
ENSG00000158711.9 | ETS transcription factor ELK4 |
ETV5
|
ENSG00000244405.3 | ETS variant transcription factor 5 |
ELK1
|
ENSG00000126767.13 | ETS transcription factor ELK1 |
ELK3
|
ENSG00000111145.3 | ETS transcription factor ELK3 |
ELF4
|
ENSG00000102034.12 | E74 like ETS transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_129240663_129241008 | ELF4 | 3501 | 0.259091 | 0.83 | 6.1e-03 | Click! |
chrX_129239548_129239983 | ELF4 | 4571 | 0.237501 | 0.82 | 6.8e-03 | Click! |
chrX_129228557_129229127 | ELF4 | 15494 | 0.199971 | 0.81 | 8.1e-03 | Click! |
chrX_129231432_129231883 | ELF4 | 12679 | 0.204772 | 0.81 | 8.4e-03 | Click! |
chrX_129242883_129243051 | ELF4 | 1369 | 0.461274 | 0.78 | 1.3e-02 | Click! |
chrX_47510988_47511234 | ELK1 | 1108 | 0.373802 | 0.69 | 4.1e-02 | Click! |
chrX_47510556_47510976 | ELK1 | 763 | 0.522883 | 0.65 | 6.0e-02 | Click! |
chrX_47507321_47507472 | ELK1 | 2491 | 0.182667 | 0.64 | 6.4e-02 | Click! |
chrX_47509275_47509426 | ELK1 | 537 | 0.667758 | 0.63 | 7.2e-02 | Click! |
chrX_47503541_47503729 | ELK1 | 6252 | 0.124311 | 0.61 | 8.4e-02 | Click! |
chr12_96602955_96603106 | ELK3 | 14638 | 0.188192 | 0.84 | 4.3e-03 | Click! |
chr12_96591690_96592082 | ELK3 | 3494 | 0.257238 | 0.68 | 4.5e-02 | Click! |
chr12_96589721_96589872 | ELK3 | 1404 | 0.453652 | 0.65 | 5.9e-02 | Click! |
chr12_96588798_96589434 | ELK3 | 724 | 0.702012 | 0.64 | 6.5e-02 | Click! |
chr12_96598576_96598727 | ELK3 | 10259 | 0.199990 | 0.61 | 8.0e-02 | Click! |
chr1_205597108_205597259 | ELK4 | 3907 | 0.192498 | 0.89 | 1.5e-03 | Click! |
chr1_205599149_205600013 | ELK4 | 1509 | 0.354166 | 0.88 | 1.6e-03 | Click! |
chr1_205595071_205595222 | ELK4 | 5944 | 0.170217 | 0.76 | 1.9e-02 | Click! |
chr1_205600093_205600244 | ELK4 | 922 | 0.533218 | 0.70 | 3.7e-02 | Click! |
chr1_205601456_205601656 | ELK4 | 466 | 0.786099 | 0.67 | 4.7e-02 | Click! |
chr3_185826394_185826545 | ETV5 | 5 | 0.983226 | 0.93 | 3.5e-04 | Click! |
chr3_185826094_185826337 | ETV5 | 118 | 0.973203 | 0.91 | 7.5e-04 | Click! |
chr3_185827310_185828065 | ETV5 | 420 | 0.874042 | 0.88 | 2.0e-03 | Click! |
chr3_185825889_185826082 | ETV5 | 348 | 0.904029 | 0.82 | 6.4e-03 | Click! |
chr3_185825439_185825590 | ETV5 | 819 | 0.685364 | 0.76 | 1.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_1158720_1158941 | 8.44 |
AC114808.2 |
|
2720 |
0.39 |
chr3_44690178_44690339 | 4.65 |
ZNF35 |
zinc finger protein 35 |
21 |
0.97 |
chr19_55665192_55665343 | 4.38 |
TNNI3 |
troponin I type 3 (cardiac) |
2826 |
0.11 |
chr17_46521887_46522400 | 3.82 |
SKAP1 |
src kinase associated phosphoprotein 1 |
14562 |
0.13 |
chr6_155272636_155272949 | 3.72 |
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
43696 |
0.14 |
chr4_99964468_99964771 | 3.50 |
METAP1 |
methionyl aminopeptidase 1 |
219 |
0.93 |
chr3_128879843_128879994 | 3.47 |
ISY1 |
ISY1 splicing factor homolog (S. cerevisiae) |
27 |
0.5 |
chr12_58138952_58139171 | 3.40 |
TSPAN31 |
tetraspanin 31 |
104 |
0.9 |
chr3_56952065_56952464 | 3.33 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
1765 |
0.42 |
chr11_63719762_63720286 | 3.33 |
NAA40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
13304 |
0.1 |
chrX_4171213_4171579 | 3.32 |
ENSG00000264861 |
. |
330145 |
0.01 |
chr22_40661821_40662040 | 3.30 |
TNRC6B |
trinucleotide repeat containing 6B |
923 |
0.66 |
chr20_3190017_3190168 | 3.26 |
ITPA |
inosine triphosphatase (nucleoside triphosphate pyrophosphatase) |
67 |
0.96 |
chr2_70891709_70891860 | 3.09 |
AC007395.3 |
|
22490 |
0.18 |
chr2_1159179_1159342 | 3.09 |
AC114808.2 |
|
3150 |
0.36 |
chr1_9007363_9007642 | 3.09 |
CA6 |
carbonic anhydrase VI |
1556 |
0.35 |
chr17_55676480_55676829 | 3.09 |
RP11-118E18.4 |
|
9119 |
0.2 |
chr20_2821713_2822010 | 3.03 |
PCED1A |
PC-esterase domain containing 1A |
25 |
0.88 |
chr19_3059606_3059757 | 3.03 |
AES |
amino-terminal enhancer of split |
1721 |
0.24 |
chr7_3134184_3134615 | 3.00 |
CARD11 |
caspase recruitment domain family, member 11 |
50820 |
0.14 |
chr2_46466937_46467126 | 2.95 |
EPAS1 |
endothelial PAS domain protein 1 |
56716 |
0.14 |
chr2_197060110_197060328 | 2.93 |
STK17B |
serine/threonine kinase 17b |
18992 |
0.17 |
chr15_77713368_77713519 | 2.92 |
HMG20A |
high mobility group 20A |
90 |
0.95 |
chr12_2802298_2802619 | 2.90 |
CACNA1C-AS1 |
CACNA1C antisense RNA 1 |
2092 |
0.31 |
chr15_71184789_71184970 | 2.89 |
LRRC49 |
leucine rich repeat containing 49 |
86 |
0.56 |
chr17_19281206_19281357 | 2.88 |
B9D1 |
B9 protein domain 1 |
78 |
0.68 |
chr19_42051966_42052728 | 2.87 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
3539 |
0.21 |
chr6_14635586_14635746 | 2.84 |
ENSG00000206960 |
. |
11100 |
0.32 |
chr19_18264331_18264482 | 2.84 |
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
478 |
0.66 |
chr2_66662179_66662389 | 2.79 |
MEIS1 |
Meis homeobox 1 |
19 |
0.96 |
chr2_8628079_8628368 | 2.78 |
AC011747.7 |
|
187673 |
0.03 |
chr14_61919103_61919361 | 2.78 |
PRKCH |
protein kinase C, eta |
9956 |
0.25 |
chr8_128313095_128313318 | 2.77 |
POU5F1B |
POU class 5 homeobox 1B |
113329 |
0.07 |
chr19_44455260_44455503 | 2.77 |
ZNF221 |
zinc finger protein 221 |
6 |
0.96 |
chr15_90920320_90920549 | 2.72 |
IQGAP1 |
IQ motif containing GTPase activating protein 1 |
11016 |
0.13 |
chr3_43066534_43066685 | 2.72 |
FAM198A |
family with sequence similarity 198, member A |
45569 |
0.13 |
chr11_10878852_10879003 | 2.72 |
ZBED5 |
zinc finger, BED-type containing 5 |
257 |
0.82 |
chr21_43493371_43493522 | 2.71 |
UMODL1 |
uromodulin-like 1 |
2020 |
0.34 |
chr17_17654067_17654522 | 2.71 |
RAI1-AS1 |
RAI1 antisense RNA 1 |
19841 |
0.13 |
chr16_66550692_66550937 | 2.68 |
TK2 |
thymidine kinase 2, mitochondrial |
3128 |
0.15 |
chr3_13275481_13275645 | 2.67 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
160946 |
0.04 |
chr2_136742943_136743094 | 2.66 |
AC093391.2 |
|
26 |
0.51 |
chr1_12148511_12148915 | 2.66 |
ENSG00000201135 |
. |
10672 |
0.15 |
chr22_39922919_39923132 | 2.65 |
RPS19BP1 |
ribosomal protein S19 binding protein 1 |
5835 |
0.15 |
chr16_85481767_85482285 | 2.64 |
ENSG00000264203 |
. |
6928 |
0.27 |
chr22_27068929_27069080 | 2.62 |
CRYBA4 |
crystallin, beta A4 |
51076 |
0.13 |
chr5_177543610_177543916 | 2.61 |
N4BP3 |
NEDD4 binding protein 3 |
3319 |
0.22 |
chr19_46002888_46003039 | 2.60 |
PPM1N |
protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) |
95 |
0.94 |
chr15_75086731_75086936 | 2.59 |
CSK |
c-src tyrosine kinase |
1448 |
0.27 |
chr13_31311606_31311867 | 2.59 |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
2091 |
0.44 |
chr19_17960122_17960273 | 2.58 |
JAK3 |
Janus kinase 3 |
1356 |
0.29 |
chr13_30944356_30944601 | 2.57 |
KATNAL1 |
katanin p60 subunit A-like 1 |
62857 |
0.13 |
chr8_27223358_27224128 | 2.57 |
PTK2B |
protein tyrosine kinase 2 beta |
14425 |
0.22 |
chr12_50453597_50453748 | 2.57 |
ASIC1 |
acid-sensing (proton-gated) ion channel 1 |
2 |
0.96 |
chr5_156644620_156644840 | 2.57 |
CTB-4E7.1 |
|
6660 |
0.14 |
chr1_2347225_2347447 | 2.57 |
PEX10 |
peroxisomal biogenesis factor 10 |
2100 |
0.18 |
chr19_6766080_6766650 | 2.54 |
SH2D3A |
SH2 domain containing 3A |
1081 |
0.38 |
chr6_170687678_170687896 | 2.52 |
RP1-140C12.2 |
|
35440 |
0.16 |
chr1_101705629_101705842 | 2.52 |
RP4-575N6.5 |
|
2979 |
0.19 |
chr12_117317698_117317992 | 2.51 |
HRK |
harakiri, BCL2 interacting protein (contains only BH3 domain) |
1048 |
0.59 |
chr12_54867307_54867458 | 2.51 |
GTSF1 |
gametocyte specific factor 1 |
1 |
0.97 |
chr7_97878450_97878874 | 2.49 |
TECPR1 |
tectonin beta-propeller repeat containing 1 |
2577 |
0.27 |
chr12_123868122_123868395 | 2.48 |
SETD8 |
SET domain containing (lysine methyltransferase) 8 |
62 |
0.97 |
chr3_67133814_67134089 | 2.48 |
KBTBD8 |
kelch repeat and BTB (POZ) domain containing 8 |
84602 |
0.11 |
chr1_20511735_20512008 | 2.48 |
UBXN10 |
UBX domain protein 10 |
707 |
0.5 |
chr12_49483027_49483203 | 2.47 |
RP11-386G11.8 |
|
876 |
0.38 |
chr19_49859367_49859600 | 2.46 |
AC010524.4 |
|
74 |
0.93 |
chr1_28571067_28571713 | 2.45 |
RP5-1092A3.4 |
|
3426 |
0.14 |
chr2_242881534_242881685 | 2.44 |
AC131097.3 |
|
5622 |
0.19 |
chr11_128598007_128598184 | 2.44 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
32177 |
0.15 |
chr8_133769660_133769811 | 2.43 |
TMEM71 |
transmembrane protein 71 |
3059 |
0.25 |
chr5_92906518_92906710 | 2.43 |
ENSG00000237187 |
. |
89 |
0.98 |
chr3_72678489_72678640 | 2.42 |
ENSG00000199469 |
. |
52722 |
0.13 |
chr14_105637441_105637645 | 2.42 |
JAG2 |
jagged 2 |
2382 |
0.26 |
chr10_94590691_94591118 | 2.41 |
EXOC6 |
exocyst complex component 6 |
31 |
0.99 |
chr4_88929574_88929774 | 2.41 |
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
854 |
0.61 |
chr12_47670226_47670510 | 2.41 |
RP11-493L12.3 |
|
2436 |
0.33 |
chr2_68966301_68966859 | 2.40 |
ARHGAP25 |
Rho GTPase activating protein 25 |
4566 |
0.29 |
chr22_38082616_38082767 | 2.39 |
NOL12 |
nucleolar protein 12 |
361 |
0.76 |
chr20_32375197_32375461 | 2.39 |
RP4-553F4.6 |
|
5504 |
0.17 |
chr22_31673878_31674099 | 2.39 |
PIK3IP1 |
phosphoinositide-3-kinase interacting protein 1 |
14393 |
0.1 |
chr17_8803738_8804136 | 2.38 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
10887 |
0.22 |
chr7_1514329_1514480 | 2.38 |
INTS1 |
integrator complex subunit 1 |
1618 |
0.31 |
chr4_40211579_40212128 | 2.37 |
RHOH |
ras homolog family member H |
9889 |
0.22 |
chr11_118563821_118563972 | 2.37 |
ENSG00000207462 |
. |
9155 |
0.12 |
chr17_14097365_14097669 | 2.35 |
AC005224.2 |
|
16288 |
0.19 |
chr20_824452_824653 | 2.34 |
FAM110A |
family with sequence similarity 110, member A |
733 |
0.73 |
chr2_69064376_69064559 | 2.34 |
AC097495.2 |
|
2331 |
0.3 |
chr19_1924695_1924846 | 2.32 |
SCAMP4 |
secretory carrier membrane protein 4 |
11681 |
0.09 |
chr6_83073756_83074156 | 2.32 |
TPBG |
trophoblast glycoprotein |
5 |
0.99 |
chr17_42386389_42386620 | 2.32 |
RUNDC3A |
RUN domain containing 3A |
540 |
0.42 |
chr1_109618543_109618694 | 2.32 |
TAF13 |
TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa |
6 |
0.96 |
chr1_21814964_21815133 | 2.32 |
ALPL |
alkaline phosphatase, liver/bone/kidney |
20810 |
0.19 |
chr1_54803697_54803848 | 2.30 |
RP5-997D24.3 |
|
52694 |
0.12 |
chr11_44338615_44338935 | 2.29 |
ALX4 |
ALX homeobox 4 |
7059 |
0.31 |
chr11_66648041_66648265 | 2.29 |
LRFN4 |
leucine rich repeat and fibronectin type III domain containing 4 |
23180 |
0.11 |
chr1_6535462_6535613 | 2.28 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
9282 |
0.11 |
chr3_47404358_47404541 | 2.28 |
RP11-708J19.1 |
|
18040 |
0.15 |
chr1_160652903_160653207 | 2.27 |
RP11-404F10.2 |
|
9743 |
0.15 |
chr9_123692600_123692841 | 2.27 |
TRAF1 |
TNF receptor-associated factor 1 |
1269 |
0.51 |
chr17_4617996_4618234 | 2.27 |
ARRB2 |
arrestin, beta 2 |
769 |
0.41 |
chr10_50746702_50746853 | 2.26 |
ERCC6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
295 |
0.34 |
chr15_92497720_92497964 | 2.26 |
SLCO3A1 |
solute carrier organic anion transporter family, member 3A1 |
100491 |
0.08 |
chr2_170219904_170220114 | 2.26 |
LRP2 |
low density lipoprotein receptor-related protein 2 |
814 |
0.73 |
chr15_41793466_41793720 | 2.26 |
ITPKA |
inositol-trisphosphate 3-kinase A |
7520 |
0.14 |
chrX_4159179_4159330 | 2.25 |
ENSG00000264861 |
. |
342287 |
0.01 |
chr12_100594827_100594978 | 2.24 |
ACTR6 |
ARP6 actin-related protein 6 homolog (yeast) |
273 |
0.83 |
chr17_45331535_45331807 | 2.24 |
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
408 |
0.78 |
chr19_6892084_6892235 | 2.23 |
ENSG00000265353 |
. |
3574 |
0.19 |
chr19_35662771_35662952 | 2.23 |
FXYD5 |
FXYD domain containing ion transport regulator 5 |
7923 |
0.11 |
chr16_68389761_68390217 | 2.22 |
SMPD3 |
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
14919 |
0.11 |
chr17_19868651_19868802 | 2.22 |
AKAP10 |
A kinase (PRKA) anchor protein 10 |
12266 |
0.17 |
chr1_65329902_65330534 | 2.22 |
RAVER2 |
ribonucleoprotein, PTB-binding 2 |
86471 |
0.09 |
chr13_111267845_111267996 | 2.21 |
CARKD |
carbohydrate kinase domain containing |
2 |
0.98 |
chr20_47426342_47426648 | 2.21 |
PREX1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
17925 |
0.25 |
chr16_50429807_50429958 | 2.21 |
BRD7 |
bromodomain containing 7 |
27037 |
0.15 |
chr2_97579351_97579510 | 2.20 |
FAM178B |
family with sequence similarity 178, member B |
15560 |
0.14 |
chr15_101675824_101676142 | 2.19 |
RP11-505E24.2 |
|
49712 |
0.14 |
chr21_43874690_43874841 | 2.18 |
ENSG00000252619 |
. |
37063 |
0.09 |
chr9_31335901_31336264 | 2.17 |
ENSG00000211510 |
. |
561856 |
0.0 |
chr1_25327851_25328032 | 2.17 |
ENSG00000264371 |
. |
22053 |
0.18 |
chr12_47756426_47756597 | 2.17 |
ENSG00000264906 |
. |
1541 |
0.44 |
chr4_48138223_48138476 | 2.16 |
TXK |
TXK tyrosine kinase |
2076 |
0.28 |
chr14_91862878_91863090 | 2.16 |
CCDC88C |
coiled-coil domain containing 88C |
20706 |
0.21 |
chr15_76050777_76050928 | 2.16 |
ENSG00000261043 |
. |
3804 |
0.12 |
chr6_159461814_159462217 | 2.15 |
TAGAP |
T-cell activation RhoGTPase activating protein |
4035 |
0.22 |
chr14_71392141_71392292 | 2.14 |
PCNX |
pecanex homolog (Drosophila) |
17760 |
0.27 |
chr2_33410_34088 | 2.14 |
FAM110C |
family with sequence similarity 110, member C |
12636 |
0.3 |
chr12_56224084_56224430 | 2.14 |
DNAJC14 |
DnaJ (Hsp40) homolog, subfamily C, member 14 |
85 |
0.93 |
chr1_27682961_27683240 | 2.13 |
MAP3K6 |
mitogen-activated protein kinase kinase kinase 6 |
138 |
0.93 |
chr1_173683932_173684083 | 2.13 |
KLHL20 |
kelch-like family member 20 |
102 |
0.96 |
chr13_30722866_30723172 | 2.11 |
ENSG00000266816 |
. |
57817 |
0.15 |
chr16_30710552_30710703 | 2.11 |
SRCAP |
Snf2-related CREBBP activator protein |
165 |
0.58 |
chr7_155252064_155252215 | 2.11 |
EN2 |
engrailed homeobox 2 |
1315 |
0.46 |
chr6_139485522_139485851 | 2.10 |
HECA |
headcase homolog (Drosophila) |
29437 |
0.2 |
chr12_68025791_68026092 | 2.10 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
16177 |
0.25 |
chr2_131130075_131130226 | 2.10 |
PTPN18 |
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
2488 |
0.23 |
chr6_33150940_33151371 | 2.09 |
COL11A2 |
collagen, type XI, alpha 2 |
9076 |
0.08 |
chr2_75067357_75067724 | 2.09 |
HK2 |
hexokinase 2 |
5243 |
0.28 |
chr5_175971785_175971975 | 2.09 |
CDHR2 |
cadherin-related family member 2 |
2368 |
0.18 |
chr8_11355176_11355492 | 2.08 |
BLK |
B lymphoid tyrosine kinase |
3435 |
0.2 |
chr7_155168249_155168526 | 2.08 |
AC008060.7 |
HCG2000720; Hypothetical gene supported by AK054822; Uncharacterized protein |
6384 |
0.18 |
chrY_19190221_19190372 | 2.07 |
ENSG00000252315 |
. |
479448 |
0.01 |
chr2_219735684_219735860 | 2.06 |
WNT10A |
wingless-type MMTV integration site family, member 10A |
9313 |
0.12 |
chr10_13142624_13142986 | 2.06 |
OPTN |
optineurin |
580 |
0.64 |
chr2_99348992_99349150 | 2.06 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
1482 |
0.47 |
chr17_4843816_4844092 | 2.04 |
RNF167 |
ring finger protein 167 |
172 |
0.69 |
chr1_173519053_173519204 | 2.01 |
RP3-436N22.3 |
|
5262 |
0.22 |
chr11_17183123_17183616 | 2.01 |
PIK3C2A |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
7919 |
0.17 |
chr12_6833069_6833220 | 2.00 |
COPS7A |
COP9 signalosome subunit 7A |
93 |
0.88 |
chr2_36474188_36474481 | 1.98 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
108735 |
0.08 |
chr10_47643266_47643467 | 1.98 |
ANTXRLP1 |
anthrax toxin receptor-like pseudogene 1 |
1425 |
0.46 |
chr11_125463014_125463199 | 1.98 |
STT3A |
STT3A, subunit of the oligosaccharyltransferase complex (catalytic) |
42 |
0.91 |
chr22_51021160_51021311 | 1.98 |
CHKB |
choline kinase beta |
193 |
0.5 |
chr17_64470803_64470954 | 1.98 |
RP11-4F22.2 |
|
57906 |
0.13 |
chr15_89943038_89943256 | 1.98 |
ENSG00000207819 |
. |
31899 |
0.15 |
chr2_134938887_134939038 | 1.97 |
ENSG00000222921 |
. |
49804 |
0.15 |
chr1_178973407_178973558 | 1.96 |
FAM20B |
family with sequence similarity 20, member B |
21457 |
0.22 |
chr7_99943449_99943600 | 1.96 |
PILRB |
paired immunoglobin-like type 2 receptor beta |
6275 |
0.09 |
chr8_19302702_19302962 | 1.96 |
SH2D4A |
SH2 domain containing 4A |
125731 |
0.06 |
chr17_71588744_71589062 | 1.96 |
RP11-277J6.2 |
|
48262 |
0.13 |
chr2_232226928_232227079 | 1.96 |
ENSG00000263641 |
. |
416 |
0.83 |
chr9_31323752_31324057 | 1.95 |
ENSG00000211510 |
. |
549678 |
0.0 |
chr11_8710556_8710707 | 1.95 |
ENSG00000212607 |
. |
3645 |
0.12 |
chr1_15904235_15904424 | 1.95 |
AGMAT |
agmatine ureohydrolase (agmatinase) |
7276 |
0.11 |
chr20_60816889_60817040 | 1.95 |
OSBPL2 |
oxysterol binding protein-like 2 |
3384 |
0.19 |
chr17_21171498_21171694 | 1.94 |
C17orf103 |
chromosome 17 open reading frame 103 |
14874 |
0.15 |
chr19_3180983_3181276 | 1.94 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
2393 |
0.19 |
chr12_72003913_72004072 | 1.94 |
RP11-186F10.2 |
|
26360 |
0.15 |
chr1_211509622_211509899 | 1.94 |
TRAF5 |
TNF receptor-associated factor 5 |
9581 |
0.25 |
chr11_64569268_64569515 | 1.94 |
MAP4K2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
1256 |
0.31 |
chr3_101798103_101798306 | 1.94 |
ZPLD1 |
zona pellucida-like domain containing 1 |
19884 |
0.27 |
chr4_38308242_38308393 | 1.93 |
ENSG00000221495 |
. |
68083 |
0.14 |
chr11_11557314_11557465 | 1.93 |
RP11-483L5.1 |
|
34242 |
0.2 |
chr5_142166474_142166910 | 1.93 |
ARHGAP26 |
Rho GTPase activating protein 26 |
14410 |
0.25 |
chr10_6525003_6525355 | 1.93 |
PRKCQ |
protein kinase C, theta |
97022 |
0.08 |
chr13_22656722_22656873 | 1.93 |
ENSG00000244197 |
. |
292121 |
0.01 |
chr11_68049320_68050034 | 1.92 |
C11orf24 |
chromosome 11 open reading frame 24 |
10220 |
0.2 |
chr12_6740807_6741147 | 1.92 |
LPAR5 |
lysophosphatidic acid receptor 5 |
162 |
0.89 |
chr20_1655542_1655700 | 1.92 |
ENSG00000242348 |
. |
8615 |
0.16 |
chr13_49078614_49078765 | 1.91 |
RCBTB2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
28524 |
0.22 |
chr10_70804099_70804254 | 1.91 |
SRGN |
serglycin |
43698 |
0.12 |
chr7_99699541_99699692 | 1.91 |
MCM7 |
minichromosome maintenance complex component 7 |
53 |
0.49 |
chr19_53073625_53073776 | 1.91 |
ZNF701 |
zinc finger protein 701 |
146 |
0.92 |
chr16_89519840_89520292 | 1.91 |
ENSG00000252887 |
. |
10340 |
0.12 |
chr3_42967856_42968007 | 1.91 |
KRBOX1 |
KRAB box domain containing 1 |
9921 |
0.13 |
chr16_12996179_12996330 | 1.91 |
SHISA9 |
shisa family member 9 |
640 |
0.78 |
chr14_68808631_68808789 | 1.91 |
RAD51B |
RAD51 paralog B |
69517 |
0.12 |
chr21_43481615_43482274 | 1.91 |
UMODL1 |
uromodulin-like 1 |
1124 |
0.52 |
chr16_30392632_30392982 | 1.90 |
SEPT1 |
septin 1 |
945 |
0.31 |
chr9_14993218_14993369 | 1.90 |
RP11-54D18.3 |
|
54766 |
0.15 |
chr4_153701035_153701186 | 1.90 |
ARFIP1 |
ADP-ribosylation factor interacting protein 1 |
2 |
0.72 |
chr16_3332966_3333146 | 1.90 |
ZNF263 |
zinc finger protein 263 |
113 |
0.93 |
chr7_99097504_99097655 | 1.89 |
ZNF394 |
zinc finger protein 394 |
308 |
0.8 |
chr13_41154720_41155232 | 1.89 |
AL133318.1 |
Uncharacterized protein |
43653 |
0.17 |
chr1_2705657_2705964 | 1.89 |
TTC34 |
tetratricopeptide repeat domain 34 |
426 |
0.88 |
chr10_125001475_125001893 | 1.89 |
ENSG00000265463 |
. |
25980 |
0.21 |
chr17_78794637_78794788 | 1.89 |
RP11-28G8.1 |
|
15280 |
0.22 |
chr1_154357957_154358230 | 1.89 |
IL6R |
interleukin 6 receptor |
19576 |
0.11 |
chr1_117359065_117359373 | 1.89 |
CD2 |
CD2 molecule |
62130 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
2.1 | 16.5 | GO:0007172 | signal complex assembly(GO:0007172) |
1.9 | 9.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.9 | 3.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.8 | 5.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.8 | 3.6 | GO:0002274 | myeloid leukocyte activation(GO:0002274) |
1.7 | 5.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.6 | 4.9 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.6 | 1.6 | GO:0051497 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
1.6 | 4.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.5 | 5.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.5 | 1.5 | GO:0002507 | tolerance induction(GO:0002507) |
1.4 | 5.8 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
1.4 | 1.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.4 | 7.0 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
1.4 | 5.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.3 | 5.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.3 | 5.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.3 | 6.5 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
1.3 | 3.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.2 | 3.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.2 | 1.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
1.2 | 3.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
1.2 | 2.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.2 | 3.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.2 | 9.2 | GO:0006491 | N-glycan processing(GO:0006491) |
1.1 | 3.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.1 | 13.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.1 | 4.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
1.1 | 3.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.1 | 1.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
1.1 | 3.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
1.1 | 1.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.1 | 2.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.1 | 6.4 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
1.0 | 6.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.0 | 7.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.0 | 1.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.0 | 3.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
1.0 | 5.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 1.0 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
1.0 | 1.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.0 | 2.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
1.0 | 1.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
1.0 | 1.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
1.0 | 2.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.0 | 4.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 4.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.0 | 1.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.9 | 1.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.9 | 5.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.9 | 1.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.9 | 0.9 | GO:0071436 | sodium ion export(GO:0071436) |
0.9 | 1.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.9 | 2.8 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.9 | 2.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.9 | 2.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.9 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.9 | 3.6 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.9 | 2.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.9 | 3.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.9 | 1.8 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.9 | 2.7 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.9 | 1.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.9 | 2.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.9 | 2.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.9 | 1.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 3.4 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.9 | 2.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.9 | 1.7 | GO:0017085 | response to insecticide(GO:0017085) |
0.9 | 1.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.9 | 3.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 2.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.8 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.8 | 3.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.8 | 0.8 | GO:0007632 | visual behavior(GO:0007632) |
0.8 | 5.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.8 | 1.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 2.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 2.5 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 1.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.8 | 3.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.8 | 1.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.8 | 1.6 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.8 | 2.4 | GO:0045056 | transcytosis(GO:0045056) |
0.8 | 2.4 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.8 | 4.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.8 | 1.6 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.8 | 2.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.8 | 2.4 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.8 | 0.8 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.8 | 3.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.8 | 0.8 | GO:0051023 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) positive regulation of immunoglobulin secretion(GO:0051024) |
0.8 | 0.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.8 | 1.5 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.8 | 3.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.8 | 1.5 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 2.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 2.3 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.8 | 3.0 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.8 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.7 | 3.0 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.7 | 6.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.7 | 9.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.7 | 3.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.7 | 3.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 2.2 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.7 | 1.5 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.7 | 2.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.7 | 3.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 2.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.7 | 2.2 | GO:0072075 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) |
0.7 | 5.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.7 | 48.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.7 | 1.5 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.7 | 2.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 2.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.7 | 2.9 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.7 | 2.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.7 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.7 | 2.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.7 | 1.4 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.7 | 2.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.7 | 2.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.7 | 3.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 0.7 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.7 | 1.4 | GO:2000696 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.7 | 0.7 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.7 | 3.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.7 | 0.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.7 | 1.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.7 | 7.0 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.7 | 0.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.7 | 2.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.7 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.7 | 2.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.7 | 1.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.7 | 1.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 2.1 | GO:0061383 | trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
0.7 | 0.7 | GO:0051318 | G1 phase(GO:0051318) |
0.7 | 2.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.7 | 0.7 | GO:0060992 | response to fungicide(GO:0060992) |
0.7 | 1.3 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.7 | 2.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.7 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 0.7 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.7 | 4.6 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.7 | 1.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.7 | 2.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.7 | 2.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 3.3 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 0.7 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.7 | 3.9 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.7 | 4.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.6 | 1.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 1.9 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.6 | 4.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.6 | 1.9 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.6 | 1.9 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.6 | 1.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.6 | 2.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.6 | 0.6 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.6 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 8.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.6 | 0.6 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.6 | 3.8 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.6 | 1.9 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.6 | 2.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.6 | 0.6 | GO:0006304 | DNA modification(GO:0006304) |
0.6 | 1.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.6 | 1.2 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.6 | 4.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 1.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.6 | 3.0 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.6 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 1.8 | GO:0071503 | response to heparin(GO:0071503) |
0.6 | 1.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.6 | 1.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 0.6 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.6 | 2.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.6 | 3.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.6 | 2.4 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.6 | 1.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.6 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.6 | 1.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 3.0 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.6 | 3.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.6 | 1.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 1.2 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.6 | 2.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 4.1 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.6 | 0.6 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.6 | 2.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 2.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.6 | 1.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 3.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.6 | 4.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.6 | 1.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 0.6 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.6 | 2.3 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.6 | 0.6 | GO:0060021 | palate development(GO:0060021) |
0.6 | 2.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 2.3 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.6 | 1.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.6 | 3.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 4.5 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.6 | 2.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.6 | 2.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.6 | 1.7 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.6 | 2.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.6 | 12.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.6 | 0.6 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.5 | 6.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 0.5 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.5 | 0.5 | GO:1901862 | negative regulation of muscle tissue development(GO:1901862) |
0.5 | 5.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.5 | 2.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 0.5 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.5 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.5 | 2.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 1.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.5 | 8.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 2.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 1.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.5 | 1.6 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 1.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.5 | 2.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 1.6 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.5 | 3.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.5 | 1.1 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002460) |
0.5 | 1.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 1.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 1.1 | GO:0031033 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 0.5 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.5 | 1.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 3.7 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.5 | 1.6 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.5 | 9.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.5 | 0.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.5 | 1.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 1.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.5 | 2.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.5 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 1.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.5 | 1.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 1.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 0.5 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.5 | 1.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.5 | 3.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 0.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.5 | 2.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 2.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.5 | 0.5 | GO:0043393 | regulation of protein binding(GO:0043393) |
0.5 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.5 | 1.0 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.5 | 1.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.5 | 2.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.5 | 0.5 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 1.5 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.5 | 1.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.5 | 1.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.5 | 2.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 7.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 0.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.5 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 2.5 | GO:0003407 | neural retina development(GO:0003407) |
0.5 | 11.8 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.5 | 2.0 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.5 | 2.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.5 | 1.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 0.5 | GO:0042695 | thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 1.5 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.5 | 1.5 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.5 | 1.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 2.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.5 | 1.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 2.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.5 | 1.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.5 | 2.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.5 | 2.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 2.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.5 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.4 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.5 | 2.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 1.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 3.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.4 | GO:0006415 | translational termination(GO:0006415) |
0.5 | 1.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.5 | 1.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.5 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 5.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.5 | 1.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.5 | 0.9 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.5 | 1.4 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.5 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 2.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.5 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.5 | 3.7 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.5 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.5 | 3.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.5 | 0.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 3.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 4.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.5 | 3.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.5 | 0.5 | GO:1990138 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.5 | 4.1 | GO:0007032 | endosome organization(GO:0007032) |
0.5 | 1.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 0.5 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.5 | 0.5 | GO:0007626 | locomotory behavior(GO:0007626) |
0.5 | 1.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.5 | 9.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.5 | 2.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 0.9 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 3.6 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 2.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 0.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.4 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.4 | 2.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.4 | 0.9 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 2.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 1.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 1.8 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.4 | 2.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.4 | 0.4 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.4 | 1.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.4 | 1.8 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.4 | 0.9 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.4 | 0.4 | GO:0072215 | regulation of metanephros development(GO:0072215) |
0.4 | 1.8 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 2.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 7.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.4 | 1.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.4 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.4 | 0.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 0.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.4 | 2.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.4 | 0.4 | GO:0031023 | microtubule organizing center organization(GO:0031023) centrosome organization(GO:0051297) |
0.4 | 3.9 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.4 | 0.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 | 7.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.4 | 4.3 | GO:0043489 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.4 | 0.4 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.4 | 0.9 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.4 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 1.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 1.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.4 | 0.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
0.4 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.4 | 0.9 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.4 | 0.4 | GO:1900181 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of nucleocytoplasmic transport(GO:0046823) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.4 | 2.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 1.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 4.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 2.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.4 | 1.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 0.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.4 | 2.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.4 | 1.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 1.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 1.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 2.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.4 | 5.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.4 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 10.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.4 | 0.8 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 1.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.4 | GO:0009179 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
0.4 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.4 | 2.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 1.7 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.4 | 1.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 2.1 | GO:1901987 | regulation of cell cycle phase transition(GO:1901987) |
0.4 | 1.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 7.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.4 | 0.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 1.6 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.4 | 0.8 | GO:0043276 | anoikis(GO:0043276) |
0.4 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 0.8 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.4 | 1.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 0.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.4 | 3.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 0.8 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 1.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.4 | 2.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.4 | 0.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.4 | 1.2 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 3.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 4.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.4 | 0.8 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) |
0.4 | 4.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 1.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 0.8 | GO:0046326 | positive regulation of glucose transport(GO:0010828) positive regulation of glucose import(GO:0046326) |
0.4 | 1.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 2.0 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.4 | 1.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 2.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.4 | 2.4 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.4 | 0.8 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.4 | 0.4 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.4 | 2.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 0.8 | GO:0021819 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.4 | 2.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 1.2 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 3.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 3.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 2.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.4 | 1.2 | GO:0090266 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 1.2 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.4 | 0.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 2.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.4 | 0.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.4 | 0.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.4 | 1.9 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.4 | 1.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.4 | 0.4 | GO:0061043 | coronary vasculature development(GO:0060976) vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.4 | 12.8 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.4 | 4.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 1.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 4.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.4 | 1.2 | GO:0033197 | response to vitamin E(GO:0033197) |
0.4 | 0.4 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.4 | 1.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 1.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.4 | 5.3 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.4 | 1.9 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.4 | 1.5 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.4 | 2.3 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.4 | 0.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.4 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.4 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 0.8 | GO:0001820 | serotonin secretion(GO:0001820) |
0.4 | 1.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.4 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 3.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.4 | 2.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.4 | 1.5 | GO:0030903 | notochord development(GO:0030903) |
0.4 | 4.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.4 | 0.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.4 | 1.1 | GO:0045926 | negative regulation of growth(GO:0045926) |
0.4 | 3.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.4 | 0.8 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.4 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 0.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.4 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 1.5 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.4 | 2.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 0.7 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.4 | 1.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 1.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 0.7 | GO:0042532 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.4 | 1.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.4 | 4.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.4 | 1.1 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.4 | 0.4 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.4 | 2.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.4 | 3.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 1.5 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.4 | 2.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.4 | 1.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 1.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 6.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.4 | 5.5 | GO:0042098 | T cell proliferation(GO:0042098) |
0.4 | 0.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 1.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.7 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 1.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 0.4 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.4 | 1.8 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.4 | 2.1 | GO:0043487 | regulation of RNA stability(GO:0043487) regulation of mRNA stability(GO:0043488) |
0.4 | 1.4 | GO:0034134 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 0.7 | GO:0072331 | signal transduction by p53 class mediator(GO:0072331) |
0.4 | 1.4 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.4 | 0.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 8.2 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.4 | 1.4 | GO:0000479 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 1.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.4 | 1.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 2.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 0.7 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.4 | 1.8 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.4 | 9.9 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 2.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 2.8 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.4 | 0.4 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.4 | 2.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.4 | 0.4 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 0.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.4 | 2.5 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.4 | 2.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.3 | 15.7 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 2.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 7.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 18.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.3 | 0.7 | GO:0045851 | pH reduction(GO:0045851) |
0.3 | 1.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 3.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.3 | 1.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 4.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 1.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.3 | 1.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 1.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 3.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 0.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.3 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 1.7 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 4.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 0.3 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.3 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 0.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 9.7 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.3 | 1.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 2.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 4.3 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.3 | 4.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 0.7 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 2.0 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.3 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 0.7 | GO:0031644 | regulation of neurological system process(GO:0031644) |
0.3 | 1.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.3 | 0.3 | GO:0097576 | vacuole fusion(GO:0097576) |
0.3 | 1.6 | GO:0007389 | pattern specification process(GO:0007389) |
0.3 | 5.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 0.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 2.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.3 | 0.6 | GO:0051299 | centrosome separation(GO:0051299) |
0.3 | 5.8 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.3 | 0.6 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.3 | 2.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 1.9 | GO:0001570 | vasculogenesis(GO:0001570) |
0.3 | 1.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 12.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 2.6 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.3 | 1.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.6 | GO:0008049 | male courtship behavior(GO:0008049) |
0.3 | 0.3 | GO:0046631 | alpha-beta T cell activation(GO:0046631) |
0.3 | 0.3 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.3 | 0.9 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.3 | 4.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.3 | 3.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.6 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.3 | 3.8 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.3 | 4.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 2.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 0.3 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.3 | 3.8 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.3 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 0.9 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.3 | 0.6 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 1.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 22.1 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.6 | GO:0006323 | DNA packaging(GO:0006323) |
0.3 | 0.9 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.3 | 0.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 0.9 | GO:0046618 | drug export(GO:0046618) |
0.3 | 1.2 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.3 | 0.3 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.3 | 2.8 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.3 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.3 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.3 | 2.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 1.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 2.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 2.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 1.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.9 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.3 | 0.6 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.3 | 2.4 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 2.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 1.8 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.3 | 0.6 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.3 | 0.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 0.6 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 0.3 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.3 | 0.3 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.3 | 0.6 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.3 | 2.4 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.3 | 0.9 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.3 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 1.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.3 | 5.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 4.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 2.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.3 | GO:0043247 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 0.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 11.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.3 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
0.3 | 0.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 4.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 2.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.3 | 0.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 2.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 0.9 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 3.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.3 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 0.3 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.3 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.3 | 3.5 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.3 | 1.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.3 | 0.9 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 0.6 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.3 | 0.9 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 2.9 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.3 | 1.7 | GO:0042119 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.3 | 0.3 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.3 | 0.3 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.3 | 26.5 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.3 | 1.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 1.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 0.3 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.3 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.9 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 2.6 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 1.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.3 | 1.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.3 | 0.6 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.3 | 0.3 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) modulation of growth of symbiont involved in interaction with host(GO:0044144) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.3 | 5.9 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.3 | 0.6 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.3 | 0.8 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.3 | 2.2 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.3 | 0.6 | GO:0045187 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle(GO:0042745) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.3 | 14.7 | GO:0006413 | translational initiation(GO:0006413) |
0.3 | 0.3 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.3 | 4.1 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.3 | 0.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.3 | 0.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 1.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 4.1 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.3 | 0.5 | GO:0033483 | gas homeostasis(GO:0033483) |
0.3 | 5.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.8 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 1.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.3 | 0.5 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 1.9 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.3 | 3.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.3 | 0.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.3 | 0.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.8 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.3 | 2.1 | GO:0010458 | exit from mitosis(GO:0010458) |
0.3 | 3.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.3 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.3 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.3 | GO:0044783 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.3 | 0.8 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.3 | 0.5 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 11.7 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 27.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.3 | 2.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.3 | 0.8 | GO:0001832 | blastocyst growth(GO:0001832) |
0.3 | 0.5 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.3 | 0.8 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.3 | 4.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.3 | 1.9 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.3 | 0.8 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.3 | 0.3 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.3 | 0.8 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.3 | 0.8 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.3 | 0.3 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 0.8 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 0.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.3 | 0.8 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.3 | 0.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.3 | 0.3 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.3 | 2.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 1.6 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.3 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.0 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 2.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 1.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 0.8 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.3 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.3 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 3.1 | GO:0097202 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) activation of cysteine-type endopeptidase activity(GO:0097202) |
0.3 | 1.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 1.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.3 | 1.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.3 | 6.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 0.5 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.3 | 0.8 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.3 | 0.5 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.3 | 9.3 | GO:0050776 | regulation of immune response(GO:0050776) |
0.3 | 0.3 | GO:0051262 | protein tetramerization(GO:0051262) |
0.3 | 1.0 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.3 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 3.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 10.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 0.3 | GO:0000726 | non-recombinational repair(GO:0000726) double-strand break repair via nonhomologous end joining(GO:0006303) |
0.3 | 1.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.3 | 1.0 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.3 | 0.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.3 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 0.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 2.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 1.5 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 0.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.3 | 1.3 | GO:0030238 | male sex determination(GO:0030238) |
0.3 | 1.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.2 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.2 | GO:0071514 | genetic imprinting(GO:0071514) |
0.2 | 0.2 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.2 | 0.5 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 0.5 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 0.7 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 7.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.2 | 10.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.5 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.2 | 0.7 | GO:0016311 | dephosphorylation(GO:0016311) |
0.2 | 17.3 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.2 | 1.2 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.7 | GO:0001889 | liver development(GO:0001889) |
0.2 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.2 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.5 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 1.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.2 | 1.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 0.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.2 | 1.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.9 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.2 | 0.9 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.2 | 0.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.5 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 5.4 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 1.4 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 0.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 17.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 0.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 1.6 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.2 | 0.7 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 28.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 3.0 | GO:0051403 | stress-activated MAPK cascade(GO:0051403) |
0.2 | 9.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 3.5 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.2 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 3.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 2.7 | GO:0016236 | macroautophagy(GO:0016236) |
0.2 | 0.7 | GO:0015853 | adenine transport(GO:0015853) |
0.2 | 1.6 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 0.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.2 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.2 | 2.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 0.2 | GO:0001708 | cell fate specification(GO:0001708) |
0.2 | 8.6 | GO:0015992 | proton transport(GO:0015992) |
0.2 | 9.4 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.9 | GO:0071242 | response to ammonium ion(GO:0060359) cellular response to ammonium ion(GO:0071242) |
0.2 | 9.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 1.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.4 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.2 | 0.2 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.2 | 1.3 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.2 | 0.4 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 2.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.2 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.2 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.7 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.2 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.2 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.2 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 1.7 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.2 | 0.2 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.2 | 2.6 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.2 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.6 | GO:0016444 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) |
0.2 | 0.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.9 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.7 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.4 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.2 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 0.4 | GO:0002682 | regulation of immune system process(GO:0002682) |
0.2 | 1.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 2.3 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.2 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 1.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 1.1 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 2.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 0.6 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.2 | 0.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.4 | GO:0006818 | hydrogen transport(GO:0006818) |
0.2 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.8 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.8 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 2.5 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 3.3 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 1.2 | GO:0001662 | behavioral fear response(GO:0001662) |
0.2 | 12.6 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 0.4 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.2 | 0.4 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.2 | 0.2 | GO:0022406 | membrane docking(GO:0022406) |
0.2 | 5.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 1.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.2 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.2 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) C21-steroid hormone metabolic process(GO:0008207) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 12.1 | GO:0006417 | regulation of translation(GO:0006417) |
0.2 | 1.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 3.9 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.2 | 0.2 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.2 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.2 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.2 | GO:0034644 | cellular response to UV(GO:0034644) |
0.2 | 4.3 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 1.6 | GO:0043666 | regulation of phosphatase activity(GO:0010921) regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.6 | GO:0007586 | digestion(GO:0007586) |
0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 1.4 | GO:0006833 | water transport(GO:0006833) |
0.2 | 1.6 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.2 | 0.6 | GO:0045055 | calcium ion regulated exocytosis(GO:0017156) regulated exocytosis(GO:0045055) |
0.2 | 0.2 | GO:0048747 | muscle fiber development(GO:0048747) |
0.2 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 1.2 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.2 | 0.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 0.4 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.4 | GO:0030728 | ovulation(GO:0030728) |
0.2 | 1.8 | GO:0048477 | oogenesis(GO:0048477) |
0.2 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 2.5 | GO:0006887 | exocytosis(GO:0006887) |
0.2 | 0.6 | GO:0008361 | regulation of cell size(GO:0008361) |
0.2 | 1.0 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.2 | 12.4 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 0.4 | GO:0040017 | positive regulation of locomotion(GO:0040017) |
0.2 | 17.2 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.2 | 1.4 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 0.4 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.2 | 0.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 1.1 | GO:0035282 | segmentation(GO:0035282) |
0.2 | 3.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.2 | 0.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.2 | 1.9 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.2 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.6 | GO:0051320 | S phase(GO:0051320) |
0.2 | 1.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.2 | 8.9 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 0.6 | GO:0051250 | negative regulation of lymphocyte activation(GO:0051250) |
0.2 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.2 | 0.9 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 1.7 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.2 | 4.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 0.6 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.2 | 1.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 1.7 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.2 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.2 | 0.2 | GO:0031645 | negative regulation of neurological system process(GO:0031645) regulation of transmission of nerve impulse(GO:0051969) negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 1.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 1.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 1.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 1.1 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.2 | 0.2 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.2 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 10.1 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.2 | 0.4 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 0.6 | GO:0009415 | response to water(GO:0009415) |
0.2 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) endoplasmic reticulum to cytosol transport(GO:1903513) |
0.2 | 0.4 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.2 | 1.1 | GO:0001825 | blastocyst formation(GO:0001825) |
0.2 | 11.0 | GO:0009144 | purine nucleoside triphosphate metabolic process(GO:0009144) ribonucleoside triphosphate metabolic process(GO:0009199) purine ribonucleoside triphosphate metabolic process(GO:0009205) |
0.2 | 2.2 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.2 | 0.5 | GO:0051169 | nuclear transport(GO:0051169) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 1.6 | GO:0007286 | spermatid development(GO:0007286) |
0.2 | 1.1 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.2 | 4.0 | GO:0006914 | autophagy(GO:0006914) |
0.2 | 0.9 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 0.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 0.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 12.1 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 21.5 | GO:0016032 | viral process(GO:0016032) |
0.2 | 0.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.2 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.2 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 6.0 | GO:0007034 | vacuolar transport(GO:0007034) |
0.2 | 1.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.2 | 0.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.9 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.2 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.7 | GO:0030282 | bone mineralization(GO:0030282) |
0.2 | 1.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.3 | GO:0002009 | morphogenesis of an epithelium(GO:0002009) |
0.2 | 3.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 2.9 | GO:0040008 | regulation of growth(GO:0040008) |
0.2 | 13.8 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.2 | 4.0 | GO:0042384 | cilium assembly(GO:0042384) |
0.2 | 0.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 1.2 | GO:0051899 | membrane depolarization(GO:0051899) |
0.2 | 0.7 | GO:0032412 | regulation of transmembrane transporter activity(GO:0022898) regulation of ion transmembrane transporter activity(GO:0032412) |
0.2 | 0.5 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.2 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.9 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.2 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 2.4 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
0.2 | 8.6 | GO:0045087 | innate immune response(GO:0045087) |
0.2 | 0.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 2.5 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.2 | 1.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.2 | 1.3 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 1.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 3.9 | GO:1903825 | anion transmembrane transport(GO:0098656) organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.2 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.2 | 0.2 | GO:0022409 | positive regulation of cell-cell adhesion(GO:0022409) |
0.2 | 0.2 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.2 | 4.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 3.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.2 | GO:0048588 | developmental cell growth(GO:0048588) |
0.2 | 0.3 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 1.5 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.5 | GO:0031638 | zymogen activation(GO:0031638) |
0.2 | 17.9 | GO:0006412 | translation(GO:0006412) |
0.2 | 0.3 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.3 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.2 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.3 | GO:0021675 | nerve development(GO:0021675) |
0.2 | 1.1 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.6 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 165.0 | GO:0006351 | transcription, DNA-templated(GO:0006351) nucleic acid-templated transcription(GO:0097659) |
0.2 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.2 | 0.3 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.2 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 10.7 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 2.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.2 | 0.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 8.2 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.2 | 0.6 | GO:0055013 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.2 | 2.2 | GO:0032259 | methylation(GO:0032259) |
0.2 | 16.4 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 1.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 0.6 | GO:0042113 | B cell activation(GO:0042113) |
0.2 | 1.2 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.2 | 0.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) cytochrome complex assembly(GO:0017004) |
0.1 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 14.0 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.9 | GO:0015813 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.1 | 1.8 | GO:0006986 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
0.1 | 0.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 2.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 1.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.7 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.1 | 1.2 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.1 | 1.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 7.6 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.7 | GO:0042391 | regulation of membrane potential(GO:0042391) |
0.1 | 37.8 | GO:0006915 | apoptotic process(GO:0006915) |
0.1 | 4.4 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 1.0 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.1 | 0.1 | GO:0051098 | regulation of binding(GO:0051098) |
0.1 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.4 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 2.4 | GO:0001666 | response to hypoxia(GO:0001666) |
0.1 | 0.8 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.1 | 0.3 | GO:0002377 | somatic diversification of immune receptors(GO:0002200) immunoglobulin production(GO:0002377) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.1 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.3 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 1.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 2.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.3 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.4 | GO:0014902 | myotube differentiation(GO:0014902) |
0.1 | 0.1 | GO:0007613 | memory(GO:0007613) |
0.1 | 0.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.1 | 0.1 | GO:0043543 | protein acylation(GO:0043543) |
0.1 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 1.6 | GO:0030278 | regulation of ossification(GO:0030278) |
0.1 | 4.1 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 4.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.5 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.3 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 1.9 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 8.2 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.6 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.1 | 0.9 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.1 | GO:0021543 | pallium development(GO:0021543) |
0.1 | 37.3 | GO:0015031 | protein transport(GO:0015031) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.1 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 4.0 | GO:0034220 | ion transmembrane transport(GO:0034220) |
0.1 | 0.5 | GO:0001775 | cell activation(GO:0001775) |
0.1 | 8.0 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.2 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.1 | 0.5 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.2 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.9 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.6 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 4.0 | GO:0008219 | cell death(GO:0008219) |
0.1 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 2.5 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.1 | 1.0 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.5 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.1 | 0.2 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.2 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
0.1 | 1.2 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.5 | GO:1990267 | response to transition metal nanoparticle(GO:1990267) |
0.1 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 10.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.7 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 0.2 | GO:0042490 | mechanoreceptor differentiation(GO:0042490) inner ear receptor cell differentiation(GO:0060113) |
0.1 | 4.5 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.1 | 0.1 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.1 | GO:0051276 | chromosome organization(GO:0051276) |
0.1 | 1.3 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.1 | 0.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 5.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.9 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.1 | GO:0033555 | multicellular organismal response to stress(GO:0033555) |
0.1 | 0.3 | GO:0010467 | gene expression(GO:0010467) |
0.1 | 0.6 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) |
0.1 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.2 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.1 | 0.4 | GO:0043473 | pigmentation(GO:0043473) |
0.1 | 0.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 7.5 | GO:0009057 | macromolecule catabolic process(GO:0009057) |
0.1 | 0.3 | GO:0009314 | response to radiation(GO:0009314) |
0.1 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
0.1 | 0.8 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.2 | GO:0046189 | phenol-containing compound biosynthetic process(GO:0046189) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.8 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.2 | GO:0048638 | regulation of developmental growth(GO:0048638) |
0.1 | 0.2 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.1 | GO:0048820 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.1 | 0.1 | GO:0051301 | cell division(GO:0051301) |
0.1 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.3 | GO:0007338 | single fertilization(GO:0007338) |
0.1 | 0.5 | GO:0034622 | cellular macromolecular complex assembly(GO:0034622) |
0.1 | 1.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.2 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 5.2 | GO:0006955 | immune response(GO:0006955) |
0.1 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.6 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 1.1 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.1 | 0.1 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.2 | GO:0016049 | cell growth(GO:0016049) |
0.1 | 0.2 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.4 | GO:0046949 | fatty-acyl-CoA metabolic process(GO:0035337) fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 1.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.1 | GO:0070307 | lens fiber cell differentiation(GO:0070306) lens fiber cell development(GO:0070307) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 3.8 | GO:0006952 | defense response(GO:0006952) |
0.1 | 0.3 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
0.1 | 0.4 | GO:0034332 | adherens junction organization(GO:0034332) |
0.1 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0046952 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 1.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.1 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.3 | GO:0030819 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.1 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.0 | 0.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.3 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
0.0 | 0.0 | GO:0009065 | arginine metabolic process(GO:0006525) arginine catabolic process(GO:0006527) glutamine family amino acid catabolic process(GO:0009065) |
0.0 | 5.5 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 12.3 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 4.7 | GO:0035556 | intracellular signal transduction(GO:0035556) |
0.0 | 0.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0072073 | kidney epithelium development(GO:0072073) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 2.2 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.4 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.1 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.0 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.2 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.2 | GO:0072001 | renal system development(GO:0072001) |
0.0 | 0.7 | GO:0009790 | embryo development(GO:0009790) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.0 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.0 | 2.8 | GO:0007276 | gamete generation(GO:0007276) |
0.0 | 0.2 | GO:0045927 | positive regulation of growth(GO:0045927) |
0.0 | 0.0 | GO:0009593 | detection of chemical stimulus(GO:0009593) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.0 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.7 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0051705 | multi-organism behavior(GO:0051705) |
0.0 | 1.5 | GO:0006644 | phospholipid metabolic process(GO:0006644) |
0.0 | 0.1 | GO:0044724 | single-organism carbohydrate catabolic process(GO:0044724) |
0.0 | 1.0 | GO:0198738 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.0 | 1.8 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 2.5 | GO:0007049 | cell cycle(GO:0007049) |
0.0 | 0.1 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.0 | 9.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 3.9 | GO:0016310 | phosphorylation(GO:0016310) |
0.0 | 0.8 | GO:0007596 | blood coagulation(GO:0007596) coagulation(GO:0050817) |
0.0 | 0.2 | GO:0018212 | peptidyl-tyrosine modification(GO:0018212) |
0.0 | 9.0 | GO:0006810 | transport(GO:0006810) |
0.0 | 0.0 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.0 | GO:0001894 | tissue homeostasis(GO:0001894) |
0.0 | 0.0 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 8.4 | GO:0008152 | metabolic process(GO:0008152) |
0.0 | 4.2 | GO:0023052 | signaling(GO:0023052) |
0.0 | 0.0 | GO:0060485 | mesenchyme development(GO:0060485) |
0.0 | 0.1 | GO:0010038 | response to metal ion(GO:0010038) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 2.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.1 | 3.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.0 | 6.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 10.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 3.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.9 | 2.7 | GO:0001652 | granular component(GO:0001652) |
0.9 | 3.5 | GO:0043218 | compact myelin(GO:0043218) |
0.8 | 8.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.8 | 7.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 8.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 3.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 11.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 0.8 | GO:0031090 | organelle membrane(GO:0031090) |
0.8 | 5.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.8 | 4.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 4.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 3.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 0.8 | GO:0098794 | postsynapse(GO:0098794) |
0.7 | 5.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.7 | 2.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.7 | 4.3 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 0.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.7 | 2.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 2.8 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.7 | 2.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.7 | 2.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.7 | 2.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.7 | 11.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.7 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.7 | 1.4 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.7 | 2.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 2.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.7 | 2.0 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 0.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 1.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.6 | 3.8 | GO:0000791 | euchromatin(GO:0000791) |
0.6 | 7.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 3.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 3.8 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.6 | 0.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 3.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 2.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 3.6 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 2.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 1.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.6 | 2.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 11.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 6.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 1.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.6 | 2.3 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.6 | 1.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 3.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 5.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.6 | 1.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 2.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.5 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 7.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 1.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.5 | 10.2 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 3.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 1.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 1.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 2.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 5.3 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.5 | 1.0 | GO:0032059 | bleb(GO:0032059) |
0.5 | 5.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 2.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 2.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 1.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 15.4 | GO:0030175 | filopodium(GO:0030175) |
0.5 | 8.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.5 | 1.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.5 | 2.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 9.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.5 | 3.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.4 | 4.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 0.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.4 | 3.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.4 | 1.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 3.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 2.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 7.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 7.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 8.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 9.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 2.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.4 | 4.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 32.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 3.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.8 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.4 | 1.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 2.7 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.4 | 0.8 | GO:0038201 | TOR complex(GO:0038201) |
0.4 | 1.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 2.7 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.4 | 25.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 5.7 | GO:0005844 | polysome(GO:0005844) |
0.4 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 7.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 2.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 2.2 | GO:0001741 | XY body(GO:0001741) |
0.4 | 1.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 3.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 2.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.4 | 15.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.4 | 2.5 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 1.1 | GO:0043025 | neuronal cell body(GO:0043025) |
0.4 | 17.0 | GO:0016605 | PML body(GO:0016605) |
0.4 | 19.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.4 | 2.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 10.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 16.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 2.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 3.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 1.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 1.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 1.0 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.3 | 1.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 4.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 3.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 4.0 | GO:0005768 | endosome(GO:0005768) |
0.3 | 8.2 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 7.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 8.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.3 | 3.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 2.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 4.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 1.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 0.6 | GO:0031430 | M band(GO:0031430) |
0.3 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 0.9 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.3 | 3.7 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 8.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 3.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 0.3 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.3 | 2.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 32.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 27.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 1.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 14.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.3 | 0.3 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 1.1 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 2.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 5.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 4.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 3.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.3 | 1.9 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 5.4 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 2.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 12.1 | GO:0000776 | kinetochore(GO:0000776) |
0.3 | 17.8 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 1.6 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.3 | 8.3 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 10.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 11.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 4.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.3 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 54.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 4.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.3 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 3.9 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.3 | 16.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 121.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 2.5 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.3 | 8.4 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.3 | 3.6 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.8 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 0.5 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 16.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 3.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 3.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.7 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 329.3 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 6.5 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.2 | 4.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.7 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 13.9 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 1.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 17.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 684.6 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 12.9 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.2 | 3.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 5.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 49.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.9 | GO:0070160 | bicellular tight junction(GO:0005923) apical junction complex(GO:0043296) occluding junction(GO:0070160) |
0.2 | 4.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 4.6 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 1.1 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.2 | 0.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 8.0 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 9.0 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 10.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 48.5 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.2 | 0.2 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 2.2 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 4.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 79.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 2.0 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.2 | 3.1 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.2 | 1.4 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 2.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 3.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.2 | 3.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 50.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 4.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.3 | GO:0098552 | side of membrane(GO:0098552) |
0.2 | 2.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 15.5 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.2 | 19.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 4.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.2 | 0.6 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.6 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.1 | 3.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.3 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 1.1 | GO:0005819 | spindle(GO:0005819) |
0.1 | 8.9 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 381.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 2.3 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 9.9 | GO:0071944 | cell periphery(GO:0071944) |
0.1 | 1.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 5.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.1 | 130.6 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 1.0 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.3 | GO:0032994 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0033267 | axon part(GO:0033267) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.8 | 5.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.5 | 4.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.4 | 17.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.3 | 3.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.3 | 5.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.3 | 3.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.3 | 7.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.1 | 3.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.1 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
1.0 | 10.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.0 | 4.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.0 | 4.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 2.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.0 | 6.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.0 | 2.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.0 | 3.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.9 | 0.9 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.9 | 11.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 2.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 5.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.9 | 2.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.9 | 15.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 2.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.9 | 8.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.9 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.9 | 4.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 13.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.9 | 3.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.9 | 2.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.8 | 3.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.8 | 3.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.8 | 2.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.8 | 2.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 2.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 2.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.8 | 31.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.8 | 2.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 1.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.8 | 4.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.8 | 3.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.8 | 2.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.8 | 0.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.8 | 3.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 3.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.8 | 5.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.8 | 3.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 2.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.7 | 2.2 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 8.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 2.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.7 | 4.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 2.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 4.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.7 | 2.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 4.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.7 | 2.1 | GO:0019863 | IgE binding(GO:0019863) |
0.7 | 5.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 2.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 2.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 2.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.7 | 2.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.7 | 2.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 2.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.7 | 6.7 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.7 | 2.0 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.7 | 3.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.7 | 4.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.7 | 5.9 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.6 | 4.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 2.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.6 | 10.6 | GO:0043621 | protein self-association(GO:0043621) |
0.6 | 3.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 1.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.6 | 7.3 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.6 | 3.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 1.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.6 | 3.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.6 | 1.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.6 | 5.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.6 | 1.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 2.9 | GO:0016208 | AMP binding(GO:0016208) |
0.6 | 4.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 1.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 1.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 2.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 1.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.6 | 1.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 2.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.6 | 2.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 1.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.6 | 4.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.6 | 1.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 1.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.6 | 1.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 11.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.6 | 11.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 7.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 3.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.5 | 2.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 1.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 6.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 1.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 3.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 4.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 1.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.5 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 1.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.5 | 2.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 1.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 1.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.5 | 3.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 1.6 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.5 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 9.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 2.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.5 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 8.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 2.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 3.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 2.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.5 | 1.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.5 | 9.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 1.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.5 | 3.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 1.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 1.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.5 | 1.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 2.5 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.5 | 1.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.5 | 5.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 0.5 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 6.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 4.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.5 | 1.4 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.5 | 3.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.5 | 1.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 3.4 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.5 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 6.2 | GO:0005035 | death receptor activity(GO:0005035) |
0.5 | 0.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 1.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.5 | 2.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 1.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 2.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 1.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 3.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 2.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 5.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 1.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.5 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 1.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 1.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 10.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 1.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 1.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 2.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 1.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 7.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 0.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.4 | 7.9 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.4 | 6.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.4 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 3.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 2.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.4 | 3.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 5.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 1.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 19.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 1.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.4 | 1.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 9.7 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.4 | 3.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 1.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 0.8 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 2.5 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.4 | 1.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 21.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.4 | 1.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 2.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 1.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 7.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 4.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 0.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 1.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.4 | 2.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 2.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 2.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 2.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 1.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 0.8 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.4 | 2.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.4 | 5.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 14.2 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.4 | 2.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 1.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 2.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 2.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 1.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 4.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 1.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 1.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 4.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 3.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 1.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 1.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 5.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.4 | 2.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 1.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.4 | 12.4 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.4 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 5.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.4 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 8.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 1.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 4.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.4 | 1.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.4 | 0.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.4 | 8.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.4 | 1.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.4 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 3.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 0.8 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 1.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 1.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 9.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 2.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.4 | 1.9 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.4 | 9.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 1.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 1.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 4.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 2.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 1.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 0.4 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.4 | 3.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 6.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 2.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 0.4 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.4 | 9.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 4.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.4 | 0.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.4 | 1.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 6.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.4 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 1.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.4 | 1.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.4 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 5.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 1.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 4.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.4 | 1.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 2.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.4 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 2.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.3 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 8.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.3 | 2.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 1.4 | GO:0015248 | sterol transporter activity(GO:0015248) cholesterol transporter activity(GO:0017127) |
0.3 | 2.4 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 1.0 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.0 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 1.7 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.3 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 2.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 1.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 2.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 1.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 17.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.3 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 8.6 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.3 | 1.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.3 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 1.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 1.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.3 | 68.7 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.3 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 4.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 0.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 0.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 1.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 6.4 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 1.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 1.3 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.3 | 4.5 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.3 | 14.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 28.4 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.3 | 4.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 4.1 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 2.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 1.6 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 4.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.3 | 1.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 2.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 8.0 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.9 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.3 | 0.3 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.3 | 3.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.9 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.3 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 9.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 0.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 1.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.3 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 1.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 6.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 2.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 2.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 3.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 2.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 2.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 0.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 1.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.3 | 1.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 2.0 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.3 | GO:0031543 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 6.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 0.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 0.8 | GO:0005497 | androgen binding(GO:0005497) |
0.3 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.8 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 0.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.3 | 0.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.3 | 1.4 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.3 | 6.2 | GO:0008144 | drug binding(GO:0008144) |
0.3 | 1.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 1.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.3 | 7.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.3 | 2.5 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.3 | 1.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 5.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 1.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 3.3 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 0.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 3.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 14.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 3.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.3 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.3 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.3 | 1.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 1.3 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 0.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 2.9 | GO:0005048 | signal sequence binding(GO:0005048) |
0.3 | 0.8 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.3 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 3.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 0.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 2.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 1.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.3 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.3 | 4.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 2.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 0.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 2.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 5.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 4.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 0.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 0.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 2.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 2.3 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.2 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 0.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 3.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 1.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 15.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 2.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 2.7 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.2 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.2 | 6.1 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 382.4 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 0.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 4.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 2.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.7 | GO:0004396 | hexokinase activity(GO:0004396) |
0.2 | 2.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 1.0 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 2.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 2.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 144.1 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.2 | 2.1 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 16.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 68.7 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.2 | 3.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 4.4 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 3.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 12.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 2.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 2.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 3.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 6.3 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.2 | 3.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 4.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 2.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 4.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 3.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 0.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 13.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 41.8 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.2 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.0 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.2 | 0.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 1.6 | GO:0071813 | low-density lipoprotein particle binding(GO:0030169) lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.2 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.4 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 2.2 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.2 | 5.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 15.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 1.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.2 | 2.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.8 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.2 | 0.6 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 1.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 7.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 1.7 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.2 | 3.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 2.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 2.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 1.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 3.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 5.8 | GO:0004871 | signal transducer activity(GO:0004871) |
0.2 | 0.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 1.3 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 14.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.3 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.2 | 3.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 3.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.2 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 5.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.2 | 1.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 3.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 1.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.2 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 6.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 2.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 18.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 4.9 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.2 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 1.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 0.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.2 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 15.4 | GO:0016874 | ligase activity(GO:0016874) |
0.2 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 19.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.2 | 2.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 8.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.2 | 2.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 23.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 2.1 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 1.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 2.5 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 4.8 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 2.4 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 4.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 2.5 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.3 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 9.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.1 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.1 | 2.3 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 2.7 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 8.8 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 0.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 1.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 2.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 3.0 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 1.1 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 2.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 1.6 | GO:0016829 | lyase activity(GO:0016829) |
0.1 | 0.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 5.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.2 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 2.4 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 2.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.4 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 8.0 | GO:0042802 | identical protein binding(GO:0042802) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 36.1 | GO:0005524 | ATP binding(GO:0005524) |
0.1 | 13.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 7.0 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 10.4 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 2.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 245.7 | GO:0005488 | binding(GO:0005488) |
0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 5.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 38.2 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.1 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.0 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.0 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 2.1 | GO:0005215 | transporter activity(GO:0005215) |
0.0 | 0.1 | GO:0016818 | hydrolase activity, acting on acid anhydrides(GO:0016817) hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.0 | 0.0 | GO:0016248 | channel inhibitor activity(GO:0016248) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 70.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.1 | 10.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.0 | 16.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.0 | 2.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.0 | 24.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.9 | 35.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.8 | 20.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 4.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 16.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 7.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.7 | 8.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 16.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 13.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 12.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.7 | 4.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 5.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 4.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 17.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 6.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 12.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 9.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 4.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 19.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 1.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 6.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 10.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 13.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 1.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 1.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 4.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 4.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 10.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 4.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 3.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 16.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 9.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 9.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 2.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 5.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.4 | 6.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 9.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 1.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 2.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 2.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 17.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 5.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 10.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 2.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 16.6 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 4.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 3.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 4.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 3.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 4.0 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 3.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 3.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 3.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 3.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 14.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 6.8 | PID ATM PATHWAY | ATM pathway |
0.3 | 5.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 3.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 2.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 2.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 3.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 2.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 2.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 5.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 3.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 5.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 3.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 6.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 7.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 2.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 4.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 3.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 8.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 9.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 2.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 4.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 3.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.7 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 26.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 1.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 3.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.4 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 3.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 12.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.5 | 6.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.4 | 17.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.4 | 15.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.3 | 9.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.2 | 16.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.1 | 1.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.0 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.0 | 1.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.0 | 2.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.9 | 22.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 18.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.8 | 14.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.8 | 3.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.8 | 3.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 6.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.8 | 9.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 17.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 7.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 7.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.7 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 7.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.7 | 7.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.7 | 1.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.7 | 3.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 3.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 16.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 0.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.6 | 14.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 1.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.6 | 7.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.6 | 7.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 4.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 4.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 2.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.6 | 11.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 1.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 4.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 18.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 7.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 9.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 3.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 8.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.5 | 2.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.5 | 1.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.5 | 29.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 14.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.5 | 4.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 1.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 5.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 5.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 1.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 6.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 6.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 2.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 1.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 2.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 2.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 3.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 19.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 5.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 4.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 4.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 5.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 2.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 2.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 4.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.4 | 3.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 1.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 5.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 0.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 7.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 0.4 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.4 | 5.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.4 | 38.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.4 | 12.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 2.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 4.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 1.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.4 | 1.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 6.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 3.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 1.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 4.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 7.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 14.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 0.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 4.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 4.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 6.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 2.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.4 | 2.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 5.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 3.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 5.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.4 | 6.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.4 | 0.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.4 | 28.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.4 | 2.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 21.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 5.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 4.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 4.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 2.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 11.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 3.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 5.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 2.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 2.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.3 | 11.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 14.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 4.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 2.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 4.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 3.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.3 | 5.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 89.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 2.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 6.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 20.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 0.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 12.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 11.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 8.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 1.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 18.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 21.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 5.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 1.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 0.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 3.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 0.5 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.3 | 1.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 4.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 5.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 4.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 4.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 28.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 0.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 5.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 2.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 2.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 10.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 3.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 4.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 4.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 1.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 2.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 3.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 3.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 3.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 3.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 11.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 4.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 4.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 1.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 3.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 6.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 3.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 3.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 4.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 0.6 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.2 | 8.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 3.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 0.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 3.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 2.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 2.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 2.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 13.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 0.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 2.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 5.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 2.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 5.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 2.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 2.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 2.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 9.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 5.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 8.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 1.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 2.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 8.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 1.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 7.0 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.2 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 2.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 3.6 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 2.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 4.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.1 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.1 | 3.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 13.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.8 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 2.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.9 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 1.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 5.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 4.2 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 6.5 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 1.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 2.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 8.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |